טוען...
Combating COVID-19 with mesenchymal stem cell therapy
The COVID-19 disease is caused by a positive stranded RNA virus called SARS-CoV-2. The virus mainly targets the pulmonary epithelial cells as it’s initial site of infection by letting its surface spike protein interact and bind to the host ACE2 receptor. The internalization and gradual replication o...
שמור ב:
| הוצא לאור ב: | Biotechnol Rep (Amst) |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7224671/ https://ncbi.nlm.nih.gov/pubmed/32420049 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.btre.2020.e00467 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|